tiprankstipranks
Advertisement
Advertisement

SUPN Stock Latest News

Supernus price target raised to $67 from $63 at Cantor Fitzgerald
The FlySupernus price target raised to $67 from $63 at Cantor Fitzgerald
24d ago
SUPN
Supernus Investors Approve Directors, Pay and Incentive Plan
PremiumCompany Announcements
Supernus Investors Approve Directors, Pay and Incentive Plan
1M ago
8K
SUPN
Supernus Reaches Milestone, Triggers Contingent Value Rights Payment
PremiumCompany Announcements
Supernus Reaches Milestone, Triggers Contingent Value Rights Payment
2M ago
8K
SUPN
SUPN: Buy Rating Reiterated as Strong Growth Supports Unchanged $65 Price Target
PremiumRatings
SUPN: Buy Rating Reiterated as Strong Growth Supports Unchanged $65 Price Target
3M ago
SUPN
Supernus Pharmaceuticals Earnings Call Signals Growth Momentum
PremiumCompany Announcements
Supernus Pharmaceuticals Earnings Call Signals Growth Momentum
3M ago
SUPN
SUPN Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsSUPN Upcoming Earnings Report: What to Expect?
3M ago
SUPN
Supernus Acquires NV-5138 Asset in New Agreement
Premium
Company Announcements
Supernus Acquires NV-5138 Asset in New Agreement
4M ago
8K
SUPN
Supernus enters into asset purchase agreement with Navitor
Premium
The Fly
Supernus enters into asset purchase agreement with Navitor
4M ago
SUPN
Supernus Pharmaceuticals Braces for 2025 U.S. Drug Pricing Orders and MFN Rules That Threaten Revenues and Global Expansion
PremiumCompany Announcements
Supernus Pharmaceuticals Braces for 2025 U.S. Drug Pricing Orders and MFN Rules That Threaten Revenues and Global Expansion
5M ago
SUPN
Supernus Pharmaceuticals Balances Record Sales With Rising Costs
PremiumCompany Announcements
Supernus Pharmaceuticals Balances Record Sales With Rising Costs
5M ago
SUPN
Supernus price target raised to $65 from $60 at TD Cowen
PremiumThe Fly
Supernus price target raised to $65 from $60 at TD Cowen
5M ago
SUPN
Buy Rating Backed by Reaccelerating Onapgo Demand, Sage Integration Upside, and Attractive CNS-Driven Valuation
PremiumRatings
Buy Rating Backed by Reaccelerating Onapgo Demand, Sage Integration Upside, and Attractive CNS-Driven Valuation
5M ago
SUPN
Closing Bell Movers: First Solar down 12% on earnings miss
PremiumThe FlyClosing Bell Movers: First Solar down 12% on earnings miss
5M ago
CCC
CWH
Supernus boosts executive pay with new equity incentives
Premium
Company Announcements
Supernus boosts executive pay with new equity incentives
5M ago
8K
SUPN
Supernus reports Q4 EPS (7c) vs 27c last year
Premium
The Fly
Supernus reports Q4 EPS (7c) vs 27c last year
5M ago
SUPN
Supernus sees FY26 revenue $840M-$870M, consensus $861.24M
PremiumThe Fly
Supernus sees FY26 revenue $840M-$870M, consensus $861.24M
5M ago
SUPN
Is SUPN a Buy, Before Earnings?
PremiumPre-Earnings
Is SUPN a Buy, Before Earnings?
5M ago
SUPN
Supernus: Zurzuvae Outperformance and High‑Margin Collaboration Revenue Underpin Buy Rating and $65 Price Target
PremiumRatings
Supernus: Zurzuvae Outperformance and High‑Margin Collaboration Revenue Underpin Buy Rating and $65 Price Target
6M ago
SUPN
Supernus Revises Merger Milestone Payment Obligations Agreement
PremiumCompany Announcements
Supernus Revises Merger Milestone Payment Obligations Agreement
6M ago
8K
SUPN
Jefferies sees potential tailwind forming for psychedelics from marijuana shift
PremiumThe FlyJefferies sees potential tailwind forming for psychedelics from marijuana shift
8M ago
ATAI
CYBN
Supernus price target raised to $55 from $50 at Stifel
Premium
The Fly
Supernus price target raised to $55 from $50 at Stifel
8M ago
SUPN
Supernus Pharmaceuticals: Strategic Growth, Clinical Advances, and Strong Financial Synergies Drive Buy Rating
Premium
Ratings
Supernus Pharmaceuticals: Strategic Growth, Clinical Advances, and Strong Financial Synergies Drive Buy Rating
8M ago
SUPN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >